Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1982 Jul;46(3):589–594.

Reduction of carrageenan- bradykinin- and histamine-induced acute inflammation by experimental eosinophilia in rats.

H Popper, O Picher, H Auer
PMCID: PMC1555312  PMID: 7095830

Abstract

An examination was made of the effects of eosinophilia on acute inflammation. Sprague Dawley rats were infected with Trichinella spiralis larvae which resulted in a blood eosinophilia. Groups of rats with the induced eosinophilia, and untreated rats without the eosinophilia, were treated with carrageenan, bradykinin or histamine in the hind paw to induce local inflammation. Paw oedema induced by carrageenan as a measure of the inflammation was much reduced in those rats with an eosinophilia, and slightly but significantly reduced in the site treated with histamine or bradykinin. Though other anti-inflammatory factors may have participated, it is believed that the reduction in inflammation was due to the eosinophils. Pretreatment of the rat paws with an eosinophil chemotactic factor tetrapeptide (ECF-A) caused no chemotaxis and therefore no effect on histamine-induced oedema.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARCHER R. K., FELDBERG W., KOVACS B. A. Antihistamine activity in extracts of horse eosinophils. Br J Pharmacol Chemother. 1962 Feb;18:101–108. doi: 10.1111/j.1476-5381.1962.tb01154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anwar A. R., Kay B. Enhancement of human eosinophil complement receptors by pharmacologic mediators. J Immunol. 1978 Oct;121(4):1245–1250. [PubMed] [Google Scholar]
  3. Bass D. A. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest. 1975 Oct;56(4):870–879. doi: 10.1172/JCI108166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bass D. A., Gonwa T. A., Szejda P., Cousart M. S., DeChatelet L. R., McCall C. E. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980 Jun;65(6):1265–1271. doi: 10.1172/JCI109789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beeson P. B. Immunology of the gut: role of the eosinophil. Ciba Found Symp. 1977 Apr 26;(46):203–223. doi: 10.1002/9780470720288.ch10. [DOI] [PubMed] [Google Scholar]
  6. Berenberg J. L., Ward P. A. Chemotactic factor inactivator in normal human serum. J Clin Invest. 1973 May;52(5):1200–1206. doi: 10.1172/JCI107287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clark R. A., Sandler J. A., Gallin J. I., Kaplan A. P. Histamine modulation of eosinophil migration. J Immunol. 1977 Jan;118(1):137–145. [PubMed] [Google Scholar]
  8. Di Rosa M., Giroud J. P., Willoughby D. A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971 May;104(1):15–29. doi: 10.1002/path.1711040103. [DOI] [PubMed] [Google Scholar]
  9. Geotzl E. J., Austen K. F. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function. Monogr Allergy. 1977;12:189–197. [PubMed] [Google Scholar]
  10. Goetzl E. J., Wasserman S. I., Austen F. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch Pathol. 1975 Jan;99(1):1–4. [PubMed] [Google Scholar]
  11. Gzarnetzki B. M., Konig W., Lichtenstein L. M. Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis. Nature. 1975 Dec 25;258(5537):725–726. doi: 10.1038/258725a0. [DOI] [PubMed] [Google Scholar]
  12. Hubscher T. Role of the eosinophil in the allergic reactions. I. EDI-an eosinophil-derived inhibitor of histamine release. J Immunol. 1975 Apr;114(4):1379–1388. [PubMed] [Google Scholar]
  13. Juan H., Sametz W. Histamine-induced release of arachidonic acid and of prostaglandins in the peripheral vascular bed: mode of action. Naunyn Schmiedebergs Arch Pharmacol. 1980 Nov;314(2):183–190. doi: 10.1007/BF00504536. [DOI] [PubMed] [Google Scholar]
  14. Kater L. A., Goetzl E. J., Austen K. F. Isolation of human eosinophil phospholipase D. J Clin Invest. 1976 May;57(5):1173–1180. doi: 10.1172/JCI108385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kay A. B. Eosinophil leucocytes: recruitment, localization and function in immediate-type hypersensitivity. Monogr Allergy. 1977;12:222–230. [PubMed] [Google Scholar]
  16. Kay A. B. Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol. 1970 Jan;6(1):75–86. [PMC free article] [PubMed] [Google Scholar]
  17. Kazura J. W., Grove D. I. Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature. 1978 Aug 10;274(5671):588–589. doi: 10.1038/274588a0. [DOI] [PubMed] [Google Scholar]
  18. König W., Czarnetzki B. M., Lichtenstein L. M. Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes. Monogr Allergy. 1977;12:198–212. [PubMed] [Google Scholar]
  19. Lembeck F., Popper H., Juan H. Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol. 1976 Jul;294(1):69–73. doi: 10.1007/BF00692786. [DOI] [PubMed] [Google Scholar]
  20. Parish W. E. Substances that attract eosinophils in vitro and in vivo, and that elicit blood eosinophilia. Antibiot Chemother (1971) 1974;19:233–270. doi: 10.1159/000395434. [DOI] [PubMed] [Google Scholar]
  21. Podleski W. K. Anaphylactic injury--a process of programmed regulation. Ann Allergy. 1977 Oct;39(4):263–265. [PubMed] [Google Scholar]
  22. Wasserman S. I., Goetzl E. J., Austen K. F. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol. 1975 Feb;114(2 Pt 1):645–649. [PubMed] [Google Scholar]
  23. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  24. Zeiger R. S., Yurdin D. L., Colten H. R. Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 2):172–179. doi: 10.1016/0091-6749(76)90152-4. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES